Home/Filings/4/0000950170-25-080457
4//SEC Filing

SEIDENBERG BETH C 4

Accession 0000950170-25-080457

CIK 0001994702other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 6:35 PM ET

Size

9.8 KB

Accession

0000950170-25-080457

Insider Transaction Report

Form 4
Period: 2025-05-29
SEIDENBERG BETH C
Director10% Owner
Transactions
  • Award

    Common Stock

    2025-05-29+16,63416,634 total
  • Award

    Stock Option (right to buy)

    2025-05-29+65,35165,351 total
    Exercise: $2.63Exp: 2035-05-29Common Stock (65,351 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    3,787,940
  • Common Stock

    (indirect: See Footnote)
    735,984
Footnotes (4)
  • [F1]Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
  • [F2]All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
  • [F3]Shares held directly by Westlake BioPartners Fund I, L.P. ("Westlake I"). The general partner of Westlake I is Westlake BioPartners GP I, LLC ("Westlake GP I"). The Reporting Person is the managing director of Westlake GP I and has sole voting and dispositive control over Westlake GP I, and disclaims beneficial ownership of the shares held by Westlake I except to the extent of the Reporting Person's pecuniary interest therein, if any.
  • [F4]Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. ("Westlake Opportunity"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC ("Westlake Opportunity GP I"). The Reporting Person is the managing director of Westlake Opportunity GP I and has sole voting and dispositive control over Westlake Opportunity GP I, and disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of the Reporting Person's pecuniary interest therein, if any.

Documents

1 file

Issuer

Kyverna Therapeutics, Inc.

CIK 0001994702

Entity typeother

Related Parties

1
  • filerCIK 0001184592

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 6:35 PM ET
Size
9.8 KB